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Abstract
Background: In the past, many methods have been developed for peptide tertiary structure prediction but they
are limited to peptides having natural amino acids. This study describes a method PEPstrMOD, which is an updated
version of PEPstr, developed specifically for predicting the structure of peptides containing natural and non-natural/
modified residues.
Results: PEPstrMOD integrates Forcefield_NCAA and Forcefield_PTM force field libraries to handle 147
non-natural residues and 32 types of post-translational modifications respectively by performing molecular
dynamics using AMBER. AMBER was also used to handle other modifications like peptide cyclization, use
of D-amino acids and capping of terminal residues. In addition, GROMACS was used to implement 210 non-natural
side-chains in peptides using SwissSideChain force field library. We evaluated the performance of PEPstrMOD on three
datasets generated from Protein Data Bank; i) ModPep dataset contains 501 non-natural peptides, ii) ModPep16,
a subset of ModPep, and iii) CyclicPep contains 34 cyclic peptides. We achieved backbone Root Mean Square
Deviation between the actual and predicted structure of peptides in the range of 3.81–4.05 Å.
Conclusions: In summary, the method PEPstrMOD has been developed that predicts the structure of modified
peptide from the sequence/structure given as input. We validated the PEPstrMOD application using a dataset
of peptides having non-natural/modified residues. PEPstrMOD offers unique advantages that allow the users
to predict the structures of peptides having i) natural residues, ii) non-naturally modified residues, iii) terminal
modifications, iv) post-translational modifications, v) D-amino acids, and also allows extended simulation of
predicted peptides. This will help the researchers to have prior structural information of modified peptides
to further design the peptides for desired therapeutic property. PEPstrMOD is freely available at http://
osddlinux.osdd.net/raghava/pepstrmod/.
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Background
There is a growing interest in the field of peptide thera-
peutics over the last decade due to numerous adverse ef-
fects of chemical drugs [1, 2]. Peptides are becoming
popular in the pharmaceutical industry due to their ap-
plications in diagnosis, therapeutics and drug delivery
with better potency, high specificity, low toxicity, and
natural availability [3–7]. Many peptide-based drugs are
successfully running in the market and many more are
in different phases of clinical trials [8]. Considering the
importance of peptides in the therapeutic market, it be-
comes imperative to know the structural information of
a novel peptide prior to its further designing for desired
therapeutic properties [9, 10]. It is well established that
the function of a peptide depends on its structure, thus
it is important to predict the tertiary structure of a pep-
tide from its primary amino acid sequence.
In the past, attempts have been made for the predic-
tion of peptide tertiary structure. In 1999, Ishikawa et al.
[11] developed an ab initio method (Geocore) for
finding the native-like structures within a small ensem-
ble of conformations. However, it was devised as a filter-
ing algorithm instead of a folding algorithm, exploring a
large conformational space (~billion conformations) and
thereby limiting its use for very small peptides. In 2007,
Kaur et al. [12] developed PEPstr algorithm to predict
the tertiary structure of small bioactive peptides. They
used predicted β-turn and regular secondary structure to
build the tertiary structure of a peptide. This approach
drastically reduced the time required to build the struc-
ture and the method provided a good starting structure
by applying the predicted restraints. Nicosia and
Stracquadanio (2008) proposed a Generalized Pattern
Search Algorithm (Gps) [13] that uses search and poll
algorithm to search the global minima. In 2009, Thomas
et al. developed PepLook algorithm [14] that is based on
Boltzmann-Stochastic technique. Maupetit et al. devel-
oped PEP-FOLD [15, 16] algorithm that is based on
Hidden Markov Model, greedy algorithm and coarse-
grained force fields. A series of 50 greedy simulations are
performed for each peptide sequence, generating 50
models. Narzisi et al. [17] proposed a multi-objective evo-
lutionary algorithm (I-PAES) for searching the conform-
ational space based on ECEPP potential energy function.
Gps, PepLook and I-PAES, all apply conformational
search strategy generating thousands of structures and
thereby they may be computationally intensive. PEP-
FOLD, however, avoids extensive searching of conform-
ational space by predicting the structural alphabets, which
are assembled to provide a starting structure followed by
simulations. Recently, Beaufays et al. [18] extended the
PepLook algorithm to handle linear and cyclic peptides
with non-proteinogenic amino acids. Thevenet et al. [19]
updated the PEP-FOLD algorithm to handle the disulfide
bonded cyclic peptides. Instead of using distance con-
straints, they used sOPEP coarse-grained force field. Shen
et al. (2014) developed PEP-FOLD2 (improved version of
PEP-FOLD) [20] and compared it with PEP-FOLD and
Rosetta on a dataset comprising 56 structurally diverse
peptides.
Thomas et al. used the Mean Force Potential (MFP) en-
ergy values to compare the structures of peptides pre-
dicted from PepLook, Robetta and PEPstr with the
experimental NMR data and concluded that PepLook and
PEPstr models closely resemble the NMR structures [21].
To the best of the authors’ knowledge, at present, only
PEPstr and PEP-FOLD methods provide free online ser-
vice to the worldwide scientific community specifically for
the prediction of tertiary structure of peptides from their
amino acid sequence. In the past few years, a number of
databases have been developed for managing peptides of
therapeutic importance that include cell-penetrating,
tumor homing, antiparasitic, hemolytic, antihypertensive,
anticancer, antimicrobial, quorum-sensing and blood–
brain barrier peptides [22–30]. Recently, a meta-database
(SATPdb) of therapeutic peptides is developed, which is
compiled from twenty-two peptide databases/datasets and
can help its users to extract moonlighting peptides with
desired function [31]. It has been observed that peptides
have poor half-life in circulation and modifications in-
crease their half-life [8, 32, 33]. Different modifications
may or may not lead to profound structural changes in
the peptide and hence influencing its biological function
[34, 35]. In the past, limited attempts have been made to
predict the structure of peptides containing non-natural
or modified amino acids.
Recently, Gfeller et al. developed SwissSideChain
database [36, 37] containing force field library for 210
non-natural residues compatible with Charmm force
field in GROMACS and CHARMM software package.
Briefly, they generated force field parameters for each
non-natural residue either from the analogous natural
side-chains or using SwissParam web service [38].
Further, Khoury et al. developed Forcefield_NCAA
(FFNCAA) [39], which is a force field library of 147
non-natural amino acids, compatible with ff03 force field
in AMBER software package. Starting from initial helical
and β-strand conformers, they performed quantum me-
chanics restrained geometry optimization and further
RESP fitting to get the force field parameters for these
non-natural residues. Khoury et al. also developed For-
cefield_PTM (FFPTM) [40], which is a force field library
of 32 frequently occurring post-translational modifica-
tions using the same procedure as described above. They
also developed web services, FFNCAA and FFPTM,
which give the facility of incorporating non-natural
amino acid and PTMs respectively to an input PDB file
and outputs the modified PDB file to the users. Petrov et
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al. [41] developed the force field parameters for ~250
different types of PTMs compatible with GROMOS
45a3 and 54a7 force fields in GROMACS. They also de-
veloped a web server Vienna-PTM [42], which gives the
facility of incorporating any PTM to a PDB file and pro-
vide the modified PDB file to the users.
In this study, we have attempted to incorporate special
force field libraries for predicting the structure of peptides
having non-natural amino acids and different types of
PTMs. We employed a logical set of steps that integrates
structure prediction software with force field libraries and
extended simulations to predict the structures of peptides
having non-natural residues and other modifications. We
evaluated the performance of PEPstrMOD application on
different datasets having modified peptides. We hope that
PEPstrMOD will help the scientific community in better
understanding of modified peptide structures.
Methods
Dataset
In order to evaluate the performance of PEPstrMOD in
handling cyclic and modified peptides, we used two
datasets. First dataset called “CyclicPep” contains 34 cyc-
lic peptides (obtained from previous studies [18, 19])
having a minimum of one and a maximum of three di-
sulfide bonds in a peptide. Second dataset “ModPep”
contains 501 peptides; each peptide has at least one
modified residue. In order to generate “ModPep” dataset,
first, we extracted 21182 PDB chains having length be-
tween 7 and 25. Next, we searched for D-amino acids,
non-natural amino acids as specified in FFNCAA and
post-translational modifications as specified in FFPTM
library and obtained 47, 72 and 692 (total 811) PDB
chains. Further, we removed peptides having disulfide
bridges and duplicate sequences. Finally, we obtained a
dataset of 501 PDB chains called ModPep dataset. We
also created a subset “ModPep16” extracted from
ModPep dataset comprising 16 peptides, which had
regular secondary structure content (helix + strand) ≥60 %.
We used DSSP software [43] to assign the secondary
structure states of residues in peptides. The eight
states (T, S, G, H, I, B, E, −) given by the DSSP soft-
ware were reduced to three states [44] in which the
states ‘G’ and ‘H’ were considered as helix, B and E
as strand and the rest of the states as coil.
Performance measures
We used standard parameters for measuring the
performance of our method that is based on Root Mean
Square Deviation (RMSD) between predicted and experi-
mentally determined structures. In this study, we com-
puted RMSD for all, only C-alpha and only backbone
atoms, which is represented here by RMSD, CA-RMSD
and B-RMSD respectively. In order to compute the
above parameters, we used Pymol Software [45]. This
software first superimposes the predicted and experi-
mentally determined structure of peptides obtained from
PDB [46], then it computes different types of RMSD.
Hydrogen atoms were removed from the original and
the predicted structures using Open Babel [47] before
computing RMSD values. If the original structure deter-
mined using NMR had multiple models, the best repre-
sentative structure as defined in the PDB file was used
as the original structure. If none of the models was de-
fined as the best representative structure, then, we used
the first model as the original structure.
Defining Rigid Core in NMR structure
Models of an NMR structure may exhibit significant
structural diversity. Therefore, it is important to perform
an ensemble-level comparison of the original and the
predicted structure only within the region of the peptide
that is rigid. We, therefore, calculated rigid core (RC)
regions in all the NMR peptide structures that had
multiple models. We used the same approach as described
by Maupetit et al. [15] except that the superposition of
NMR models was performed using PROFIT software.
Briefly, RC region is defined as residues which exhibit
<1.5 angstrom (Å) C-alpha RMS fluctuation.
PEPstr algorithm
The PEPstr method is explained in detail elsewhere [12],
here is a brief overview of PEPstr. This algorithm was
developed based on an important observation that β-
turns are the major structural constituent of bioactive
peptides [48]. PEPstr uses β-turns and secondary struc-
ture (Helix, Sheet, Coil) information predicted using
BetaTurns and PSIPRED software respectively [44, 49].
The ideal torsion angles (φ, ψ) of the secondary struc-
ture (helix: φ = −60, ψ = −40; strand: φ = −120, ψ = 120)
and β-turn types [50] are used as restraints. These re-
straints are used to generate the initial structure using
the tleap module of AMBER v6.0. Further, side-chain
torsion angles (χ) are assigned to the initial structure
using backbone dependent rotamer library [51]. The
structure is further energy minimized followed by a
short NTP molecular dynamics simulation for 25 pico-
second (ps) at 300 K using SANDER module of AMBER
with a non-bonded cut-off value of 8 Å. After simula-
tions, a short energy minimization of the structure is
performed and the final tertiary structure is predicted.
PEPstrMOD algorithm
The original PEPstr method is updated to incorporate
most of the generally occurring modifications in the
peptides such as terminal modifications, D-amino acids,
non-natural amino acids, post-translational modifica-
tions, etc. Fig. 1 shows a graphical representation of the
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algorithmic steps followed by PEPstrMOD. First, a user
selects the desired modification or insertion in a given
peptide sequence at different positions. Next, the pro-
gram predicts the secondary structure using PSIPRED
and β-turn types using BetaTurns. If the modification in-
corporated by the user involves any non-natural residue
then it is converted to ‘X’ in the peptide sequence before
input to PSIPRED and BetaTurns. The ideal torsion
angles (φ, ψ) of the secondary structure (helix: φ = −60,
ψ = −40; strand: φ = −120, ψ = 120 and β-turn types) are
assigned to each residue based upon the predicted sec-
ondary structure and β-turn types. The force field li-
braries (FFNCAA, FFPTM and SwissSideChain) are
used to handle the modifications selected by the user in
the peptide sequence. After modification in the peptide
sequence, an initial structure is generated using tleap
module of AMBER v11.0 [52, 53]. The initial structure
is subjected to energy minimization and molecular dy-
namics using either AMBER11 (for FFNCAA/FFPTM)
or GROMACS (version 4.6.5) [54, 55] (for SwissSide-
Chain) to generate the final peptide structure.
Updates and modifications in PEPstrMOD
The updated web server PEPstrMOD (PEPstr with
modified residues) can handle natural as well as modi-
fied peptides. Apart from incorporation of these modifi-
cations, the simulations are performed using AMBER
v11.0 instead of old v6.0. The GROMACS (version 4.6.5)
molecular dynamics software package is also used for
implementing the SwissSideChain force field library.
Table 1 shows different modifications, which can be han-
dled using PEPstrMOD and the resources used to handle
such modifications. The modifications incorporated in
the PEPstrMOD are described below.
Terminal modifications
The most common terminal modifications are acetyl-
ation at N-terminus and amidation at C-terminus. These
terminal modifications protect the peptides from degrad-
ation by exopeptidases. PEPstrMOD uses inbuilt func-
tions present in the AMBER11 package to incorporate
acetylation at N-terminus and amidation/N-methyla-
mide modification at C-terminus and predicts the pep-
tide conformation.
Stereo-chemical modifications
Replacement of L-amino acid by stereo-chemically
modified D-amino acid helps in providing stability to the
peptide from enzymatic breakdown. It can also provide
insights into the stereo-structural requirements of cer-
tain secondary structures (promoting reverse β-turn
conformations), which play an important role towards
the bioactivity of the peptide [56]. PEPstrMOD uses
“flip” command of AMBER11 to replace the L-amino
acid with the D-amino acid.
Peptide cyclization
In order to restrict the conformational flexibility and to
provide additional stability, peptides are cyclized either
terminally (N-C cyclization) or by covalent side-chain
Fig. 1 Graphical representation of algorithmic steps of PEPstrMOD showing its working
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cyclization using disulfide bridge between thiol group of
two cysteine residues. To achieve N-C cyclization, PEPstr-
MOD uses inbuilt “bond” command of AMBER11 to build
a bond linking the N-terminal amino group with the C-
terminal carboxyl group. Similarly, for disulfide linkage, the
SG atoms of the thiol group of two cysteine amino
acids are covalently linked (using “bond” command in
AMBER11) to achieve side-chain-to-side-chain cyclization.
Non-Natural modifications
Common non-natural modifications include, but are not
limited to, N-Alkylation, Cα-tetrasubstituted α-amino
acids (e.g. Aib [α-amino butyric acid]), β-substituted
amino acids, etc. These non-natural amino acids cannot
be directly handled by standard force field libraries im-
plemented in AMBER and GROMACS. PEPstrMOD
uses special force field libraries FFNCAA and SwissSide-
Chain, to incorporate these non-natural amino acids in
the peptide followed by energy minimization and
molecular dynamics to generate the tertiary structure
of the peptide having these modifications. Briefly,
FFNCAA library contains parameters for 147 non-
natural/noncanonical amino acids, which are compatible
with AMBER software package, and SwissSideChain
represents 210 non-natural amino acids with both L-
and D-configurations, which are compatible with GRO-
MACS software package. Together, these libraries
represent diverse modifications, which include alkyl-
ation, β-amino acids, methoxylation, halogenation, sul-
fones, etc. The list of non-natural amino acids from
FFNCAA and SwissSideChain force field libraries is avail-
able in the Additional file 1: Table S1.
Post Translational Modifications (PTMs)
Many functional aspects of proteins/peptides are regulated
through PTMs. PTMs (e.g. phosphorylation, hydroxyl-
ation, etc.) regulate a variety of functions like regulation of
gene expression, signaling cascades, etc. With the avail-
ability of special force field library for PTM (FFPTM), de-
veloped using quantum-chemical level, the integration
and use of these force fields in PEPstrMOD makes it feas-
ible to study the effect of PTMs on the structure of pep-
tides. Briefly, FFPTM library consists of parameters for 32
common PTMs (e.g. phosphorylation, acetylation, hydrox-
ylation, palmitoylation, farnesylation, etc.), which are com-
patible with AMBER software package. The list of PTMs
from FFPTM force field library is available in the
Additional file 1: Table S2.
Molecular dynamics details
Due to the compatibility issues of the available force
fields, we used two molecular dynamics software pack-
ages, AMBER version 11 (compatible with FFNCAA and
FFPTM libraries) and GROMACS version 4.6.5 (compat-
ible with SwissSideChain library). A non-bonded cut-off
value of 10 Å was used and minimization was performed
for 2000 steps (1000 steps with steepest descent and rest
of the steps with conjugate gradient algorithm). Next,
the system was heated for 50 ps (ps) using NVT ensem-
ble (at 300 K) and then equilibrated for 50 ps at NPT
ensemble (at pressure of 1 bar). Finally, production mo-
lecular dynamics was performed at 300 K temperature
and 1 bar pressure with a time step of 1 femtosecond.
For performing simulation in water, TIP3P [57] and SPC
[58] water models were used in AMBER and GROMACS
Table 1 Types of peptides that can be handled with different modifications and the resources used to handle such modifications
Module name Brief description Resources used
Natural peptides Prediction of peptides having natural residue. PEPstr algorithm using AMBER11.
D-amino acids Incorporation of D amino acids in a peptide. Using inbuilt ‘flip’ command in AMBER11
Terminal modifications Acetylation at N-terminus and/or amidation/
N-methylamide group at C-terminus.
Using existing force field parameters in AMBER11.
Peptide cyclization N-C cyclization of peptides or peptides having
disulfide bridges.
Using inbuilt ‘bond’ command in AMBER11.
Non-natural modification Incorporation of any of the 147 non-natural
residues. (e.g. Homoserine, N-alkylated residues,
β-substituted residues etc.).
FFNCAA library comprising 147 non-natural
residues compatible with AMBER11.
Incorporation of any of the 210 non-natural
residues. (e.g. Ornithine, Norvaline, Halogenated
residues etc.).
SwissSideChain library comprising 210 non-natural
residues compatible with GROMACS.
PTMs of residue Peptides with any of the 32 diverse PTMs.
(e.g. phosphorylation, palmitoylation,
hydroxylation etc.).
FFPTM library compatible with AMBER11.
Advance modification Combination of all the above six modules to
provide facility to incorporate multiple
modifications in one step.
All the resources used in the above modules.
Structure simulations Facility to provide extended simulations. All the resources used in the above modules.
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respectively and for simulations in hydrophobic environ-
ment, methane box was used. The simulation time (50/
100 ps) can be selected by the user. Simulation can be per-
formed either in water, hydrophobic or vacuum environ-
ments. In vacuum environment, the system was heated for
50 ps (at 300 K) followed by production molecular dy-
namics (at temperature of 300 K) with no periodic bound-
ary conditions. All the parameters corresponding to
molecular dynamics simulations in AMBER and GRO-
MACS used in PEPstrMOD are provided in Additional file
1: Table S3 and S4.
Results and discussion
PEPstrMOD implements the original PEPstr algorithm
and incorporates modified residues using force field li-
braries. The PEPstr algorithm has already been bench-
marked on a set of 42 bioactive peptides [12]. Other
methods, like PEP-FOLD, also compared and evaluated
the performance of PEPstr algorithm with their methods
[15, 16]. Here, we evaluated the application of PEPstr-
MOD in handling the peptides having modified residues.
Table 2 shows the types of modifications implemented
in the PEPstrMOD method along with the availability of
these modifications in other peptide tertiary structure
prediction methods.
Performance of PEPstrMOD on CyclicPep dataset
We cyclized the structure of peptides using PEPstrMOD
and computed its performance to determine its utility in
peptide cyclization. In order to provide a direct compari-
son with the existing method PEP-FOLD, we used PEP-
FOLD server for computing structure of peptides. We
predicted the structure of each peptide in CyclicPep
dataset using PEP-FOLD server without giving disulfide
bond constraints. Next, we used PEPstrMOD for
cyclization of these predicted peptide structures
using “Structure Modification” sub-module of “Peptide
Cyclization” module. We represent these cyclic peptide
structures by set PEPstrMODpc. We also predicted the
cyclic structure of peptides in CyclicPep dataset using
PEP-FOLD with disulfide bond constraints given to the
PEP-FOLD. We represent these cyclic peptide structures
computed directly from PEP-FOLD by set PEP-FOLDc.
Finally, we evaluated the performance of peptide struc-
tures in both PEPstrMODpc and PEP-FOLDc. As shown
in Table 3, PEP-FOLDc achieved an average CA-RMSD of
4.16 Å while PEPstrMODpc achieved 4.06 Å respectively.
These results indicate that PEPstrMOD has the ability to
cyclize the peptide structure with reasonable precision,
comparable to existing server PEP-FOLD. Out of 34 pep-
tides, PEPstrMOD performed better than PEP-FOLD in
terms of B-RMSD for almost half of the cases and vice
versa (Additional file 2: Table S5). Considering the differ-
ence in B-RMSD of >1 Å, PEPstrMOD performed better
than PEP-FOLD in 10 cases while PEP-FOLD was better
in 7 cases (Additional file 2: Table S5). In the rigid core
(RC) region, the same trend was observed i.e. the overall
performance of PEPstrMOD and PEP-FOLD was compar-
able with average CA-RMSD of 3.69 Å and 3.74 Å re-
spectively (Additional file 2: Table S5).
We also extended the duration of MD simulations
from 100 ps to 1 nanosecond (ns) and compared the
performance of PEPstrMOD at both of these time steps.
We did not observe any improvement in the results by
extending the MD runs (Additional file 2: Table S5). We
also repeated the above experiments while performing
the MD simulations in hydrophilic environment instead
of vacuum (Additional file 2: Table S6). PEPstrMOD
achieved an average CA-RMSD of 3.97 Å in hydrophilic
environment, which is slightly better as compared to the
Table 2 Types of modifications available in PEPstrMOD and availability of these modifications in other methods
Prediction methods Natural peptides structure prediction Peptide modifications
N and C terminal L/D Cyclization Non-natural residues covered PTM Availability
PEPstrMOD Y Y Y Y 210a +147b 32c Web-service
PEP-FOLD (2012) Y N N Y N N Web-service
PepLook −2011 Y N Y Y ~19 N N
Narzisi et al. (2010) Y N N N N N N
PEP-FOLD (2009) Y N N N N N Web-service
PepLook −2009 Y N N N N N N
Gps −2008 Y N N N N N N
PEPstr −2007 Y N N N N N Web-service
Geocore −1999 Y N N N N N N
Y: Available
N: Not-Available
alist of non-natural residues from SwissSideChain library
blist of non-natural residues from FFNCAA library
clist of non-natural residues from FFPTM library
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performance in vacuum. The performance was further
improved from 3.97 Å to 3.82 Å (CA-RMSD) by extend-
ing the duration of MD runs from 100 ps to 1 ns in
hydrophilic environment (Additional file 2: Table S6).
Due to the unavailability of PepLook service, we
were unable to perform the same experiments (like
PEPstrMODpc) using initial structure predicted from
PepLook; however, we report the result of PepLook,
Table 3 The performance of different methods on peptides in CyclicPep dataset. All models were subjected to 100 ps molecular
dynamics simulations in vacuum environment
ab initio model PEP-FOLDc PEPstrMODpc
PDB ID La CA-RMSD B-RMSD CA-RMSD B-RMSD CA-RMSD B-RMSD
1n0c 10 2.98 2.31 2.30 1.83 0.99 0.83
1n0a 11 3.61 3.92 0.50 0.41 1.09 1.21
1etl 12 2.07 2.10 3.14 2.47 2.51 2.46
1im1 12 3.76 3.86 1.85 1.90 2.39 2.44
1gnb 13 3.45 3.06 5.18 5.13 3.84 3.86
1hje 13 3.56 3.60 3.64 3.64 3.85 2.47
1im7 13 4.33 3.51 4.07 3.74 3.73 3.55
1xgb 13 3.91 3.44 3.59 3.59 2.51 2.62
2i28 13 3.29 3.23 1.16 0.79 4.66 4.24
1b45 14 2.93 1.97 3.74 2.17 3.98 2.36
1jbl 14 4.26 3.36 2.10 2.05 4.01 3.13
1r8t 15 3.22 2.97 3.84 3.70 2.33 2.08
1kwd 16 2.24 2.58 2.76 2.18 4.58 4.53
1mii 16 4.35 4.36 0.86 0.88 2.69 2.46
2efz 16 5.37 5.27 4.54 3.75 3.40 3.31
1nim 17 4.35 4.40 3.68 3.53 5.54 5.37
1ien 19 5.01 4.70 2.54 2.44 2.49 3.46
1x7k 19 4.79 4.73 5.03 4.92 4.43 4.28
1kcn 21 4.49 4.41 6.17 5.74 6.58 6.24
1rpc 21 6.34 6.36 5.86 5.85 6.03 5.96
1ter 21 7.39 7.26 5.57 5.44 2.56 2.64
1v6r 21 7.08 7.03 5.91 5.88 5.69 5.85
1 hp9 22 5.35 5.38 2.76 2.70 2.40 2.03
2ajw 22 4.88 4.76 0.99 0.83 2.81 2.64
1oig 24 6.82 6.69 5.56 5.59 6.16 6.14
1orx 24 7.61 7.41 6.97 6.81 5.85 5.85
1sp7 24 6.40 6.46 6.47 5.60 5.98 3.80
2oq9 24 6.28 5.76 9.73 9.56 6.36 5.90
1wqc 26 6.57 5.03 1.19 1.12 2.10 2.07
1v5a 28 6.28 6.17 5.06 4.84 3.93 3.76
1wm8 28 7.78 7.87 6.87 7.07 7.89 7.69
2it7 28 7.05 7.06 5.59 5.43 4.40 4.25
2nx7 28 5.65 5.68 6.40 6.31 4.61 4.32
1mmc 30 7.76 6.01 5.97 5.61 5.80 5.70
Average 5.04 4.78 4.16 3.93 4.06 3.81
PEP-FOLDc: PEP-FOLD predicted peptide structure using cyclic (disulfide bond) constraints
PEPstrMODpc: PEPstrMOD predicted peptide structure using cyclic (disulfide bond) constrains
CA-RMSD C-alpha Root Mean Square Deviation, B-RMSD Backbone Root Mean Square Deviation
aLength of the peptide
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PEP-FOLD and PEPstrMOD on a subset (28 common
peptides) of this dataset (Additional file 2: Table S7).
The results on 28 cyclic peptides follow the same
trend with average CA-RMSD values of 3.91 Å and
3.95 Å by PEPstrMODpc and PEP-FOLDc respectively.
A difference of 0.32 Å is observed in the average B-
RMSD values of PEP-FOLD (without constraints) and
PEP-FOLD# (results as reported in PepLook Study).
This may be because the PEP-FOLD server was up-
dated after the PepLook study. (Additional file 2:
Table S7).
Performance of ab initio models on CyclicPep dataset
One might argue that the moment one connects the cor-
rect cysteine residues in peptides via disulfide bridges,
the near-correct topology is immediately attained, espe-
cially for very short peptides. In other words, we might
not need a sophisticated prediction method for cyclic
peptides as merely connecting the correct cysteine resi-
dues in peptides followed by geometry optimization,
may provide a near-correct topology/structure. To ad-
dress this point, we performed an additional experiment
and predicted the ab initio models using an extended
conformation with disulfide bond constraints and sub-
jected to 100 ps MD simulation and extended up to
1 ns. We compared the performance of ab initio models
with PEPstrMOD. PEPstrMOD achieved an average
CA-RMSD of 4.06 Å while ab initio model achieved
5.04 Å (Table 3). We observed no improvement in
the results by extending MD simulation up to 1 ns.
Even in the case of very short peptides, PEPstrMOD
performed better than ab initio models. Figure 2
shows an example of a short cyclic peptide (10 residues)
where PEPstrMOD approached close to the native struc-
ture while the ab initio model performed poor. In the RC
region, PEPstrMOD achieved an average CA-RMSD of
3.69 Å while ab initio models achieved 4.61 Å. The same
trend was observed when the MD simulations were per-
formed in hydrophilic environment (Additional file 2:
Table S6).
Performance of PEPstrMOD on ModPep dataset
In order to demonstrate the application of our algo-
rithm, we implemented it on peptide structures in the
ModPep dataset. This dataset contains 501 peptides
whose structures are available in the PDB and each pep-
tide has at least one modified residue. We predicted the
structure of each peptide using our algorithm and gener-
ated an initial structure (starting structure). In the next
step, we performed energy minimization on the initial
structure to get the minimized structure. Next, we com-
pared our predicted structures with the actual structures
in order to compute the performance of our algorithm
in terms of RMSD values.
The initial structure obtained using PEPstrMOD achieved
an average CA-RMSD and B-RMSD of 4.21 Å and 3.96 Å
respectively. After energy minimization, the performance
improved to average CA-RMSD and B-RMSD of 4.12 Å
and 3.85 Å respectively. In the RC region, the initial
and minimized structure achieved an average B-RMSD of
3.76 Å and 3.64 Å respectively (Additional file 2:
Table S8). We did not perform the MD simulations
on all of the 501 peptides but only on a subset of
501 peptides, which had regular secondary structure
content ≥60 % (ModPep16 dataset) and its results are
described in the following sections.
Fig. 2 A case study of the comparison of PEPstrMOD and ab initio model of a short cyclic peptide (1n0c)
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Performance of PEPstrMOD on ModPep16 dataset
ModPep16 dataset contains 16 peptides and is a subset
of ModPep dataset. These peptides have regular second-
ary structure content (helix + strand) ≥60 %. We com-
pared the initial structure, minimized structure and the
structure generated after performing 100 ps MD simula-
tions with the actual structures to compute the perform-
ance of PEPstrMOD on these peptides. The initial
structure generated by PEPstrMOD achieved an average
CA-RMSD of 4.83 Å while the performance of mini-
mized structure and structure after 100 ps MD simula-
tions improved to 4.78 Å and 4.31 Å respectively
(Additional file 2: Table S9-S11, Table 4). We observed
no improvement in the results by extending MD simula-
tion from 100 ps to 1 ns (Additional file 2: Table S9−S12).
Performing MD simulations in hydrophilic environment
also produced similar results with an average CA-RMSD
of 4.35 Å as compared to 4.31 Å in vacuum (Add-
itional file 2: Table S13−S15).
Performance of ab initio and DSSP models on ModPep16
dataset
PEPstrMOD is based on predicted secondary structure,
and therefore, its performance depends on the method
used for predicting the secondary structure of peptides.
In order to understand the advantages and limitations
of secondary structure prediction method used in
PEPstrMOD, we developed two additional models.
Firstly, we developed ab initio model in which no
secondary structure information was used. Secondly,
we developed the model based on the observed or
actual secondary structure (assigned using DSSP)
called DSSP model. The performance of these models
is shown in Additional file 2: Table S9−S11 and
Table 4. We achieved an average CA-RMSD of 10.94 Å
for initial structure generated by ab initio models, which
improved slightly with energy minimization step
(10.77 Å). As shown in Table 4, ab initio models achieved
an average CA-RMSD 5.48 Å after MD simulations of
100 ps. The performance of PEPstrMOD (4.31 Å) is far
better than ab initio models that show the importance of
predicted secondary structure in model building (Table 4
and Additional file 2: Table S9−S11).
The performance of initial structure of DSSP model
achieved an average CA-RMSD of 2.78 Å, which re-
duced with energy minimization step (2.90 Å) and finally
reached to 3.80 Å after performing 100 ps MD simula-
tion (Additional file 2: Table S9−S11). This is due to the
fact that the initial structure of DSSP model already
achieves a very good starting point due to original struc-
tural restraints and there is no scope of further improve-
ment of this structure by MD runs. These results clearly
indicate the limitations of secondary structure prediction
methods used in our method PEPstrMOD. Thus there is
Table 4 The performance of different models on 16 peptides in ModPep16 dataset. All models were subjected to 100 ps molecular
dynamics simulations in vacuum environment
ab initio model PEPstrMOD DSSP model
PDB ID La CA-RMSD B-RMSD CA-RMSD B-RMSD CA-RMSD B-RMSD
1fevA 15 5.25 5.12 2.20 2.57 1.82 1.78
1rbdS 15 5.16 5.07 4.86 4.93 5.64 5.08
1tkqB 15 6.46 5.51 6.11 5.95 5.65 5.46
1z3lS 15 5.93 5.45 4.28 3.33 4.78 4.65
1z3mS 15 5.57 5.49 4.81 4.94 3.67 1.73
1z3pS 15 3.39 3.61 4.16 3.90 6.72 6.62
2ap8A 20 4.72 4.78 1.37 0.90 1.17 0.91
2dprA 21 5.60 5.41 1.65 1.52 0.92 0.90
2fx8P 12 4.17 4.15 4.76 4.77 0.88 0.78
2k7lB 19 5.99 6.04 6.60 6.44 0.90 0.98
2rlnS 15 4.16 4.00 6.07 4.69 6.69 2.55
3cmhA 15 5.21 5.26 4.83 4.75 4.59 4.41
3kmzC 19 5.32 4.83 1.69 1.24 2.65 2.77
3zs2D 25 7.23 7.33 5.23 4.85 5.86 5.70
4lkaB 12 4.65 3.93 4.39 4.17 3.25 2.73
6cmhA 21 8.81 8.71 5.96 5.80 5.56 3.87
Average 5.48 5.29 4.31 4.05 3.80 3.18
CA-RMSD C-alpha Root Mean Square Deviation, B-RMSD Backbone Root Mean Square Deviation
aLength of the peptide
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a need to develop better methods for predicting the sec-
ondary structure of peptides as presently we are using
secondary structure prediction methods developed for
proteins. In summary, the performance of PEPstrMOD
is better than ab initio model but poorer than DSSP
model.
Performance of PEPstrMOD on peptides with different
length distributions
We divided CyclicPep and ModPep datasets into three
subsets based on the length distribution of the peptides.
We ensured that each subset contains sufficient number
of peptides. On both the datasets, the performance of
PEPstrMOD decreased with the increase in length of the
peptide. On CyclicPep dataset, the average B-RMSD
achieved by PEPstrMOD was 2.6 Å, 4.06 Å and 4.95 Å
in the length range of 10–15, 16–22 and 23–30 amino
acids respectively (Table 5). Analyzing peptides with
poor performance (>5 Å B-RMSD), a general trend is
that both the methods viz. PEPstrMOD and PEP-FOLD
tend to perform poor when the length of the peptide is
>20 residues (8 cases with PEPstrMOD and 12 cases
with PEP-FOLD out of total 16 cases) (Table S5). A
similar trend was observed on ModPep dataset with
average B-RMSD of 2.91 Å, 4.75 Å and 5.44 Å in the
length range of 7–10, 11–15 and 16–25 amino acids re-
spectively (Table 5).
Justification of Force Fields
The force field parameters implemented in PEPstrMOD
are adopted from FFNCAA/FFPTM/SwissSideChain and
are evaluated and validated in their corresponding
research work [37, 39, 40]. Briefly, the force field param-
eters derived in FFNCAA and SwissSideChain were vali-
dated by predicting the binding free energy of a set of
analogs and correlating it with experimental values. The
force field parameters derived in FFPTM were validated
by comparing the RMSD differences between the ori-
ginal natural PDB structure plus desired modified
residue (followed by molecular dynamics) and the
modified PDB structure. They observed the final state
of the structure to be same with comparable side-
chain distributions. Moreover, in our study, we ob-
served that using the force fields of modified residues,
PEPstrMOD is able to approach towards the native
structure (Additional file 2) which further validates the
application of this study.
Web Implementation
There are eight modules in PEPstrMOD, which can han-
dle different modifications in a peptide. The name of
these modules and their brief description is provided in
Table 1. Each module has sub-modules, which can take
either sequence or structure of the peptide as input. The
‘Structure Modification’ sub-module (implemented in all
the modules) takes peptide structure as an input and
gives an option to further modify the peptide structure.
Other sub-modules, which take peptide sequence as input,
are generally named either ‘Beginner’ or ‘Expert’ with the
former being very easy to use. We have integrated differ-
ent software and tools [43, 59, 60] to visualize and analyze
the results obtained using PEPstrMOD (Fig. 3a, f). A de-
tailed manual for using the online service of PEPstrMOD is
available at (http://osddlinux.osdd.net/raghava/pepstrmod/
pepstrmod_manual.pdf). PEPstrMOD web server can be
accessed at http://osddlinux.osdd.net/raghava/pepstrmod/.
Execution time
The total time required to predict the peptide structure
using PEPstrMOD server depends on two factors. i)
Environment (vacuum/hydrophilic/hydrophobic) in which
the peptide needs to be simulated, which is selected by the
user. In vacuum environment, at 100 ps MD simulation,
the job is completed in ~5–8 min while in hydrophilic/
hydrophobic environment the job can take up to ~45–60
min. ii) PEPstrMOD uses queue system where one query
is processed at a time on ‘first-come, first-serve’ basis. To
fasten the predictions, we have implemented three separ-
ate queue systems, one each for vacuum, hydrophilic and
hydrophobic environments.
Conclusions
Peptide-based therapeutics is currently being used for
many diseases and disorders like diabetes, hypertension,
heart attack, osteoporosis, cancer, hypothyroidism, acro-
megaly, infertility, bacterial infections, viral infections,
Table 5 The performance of PEPstrMOD on peptides in
CyclicPep and ModPep datasets having length in different
range. All models were subjected to 100 ps molecular dynamics
simulations in vacuum environment
CyclicPep dataset
Length range Peptidesa CA-RMSD Percentb B-RMSD Percentb
10–15 12 2.99 100 2.60 100
16–22 12 4.10 66.7 4.06 66.7
23–30 10 5.31 40 4.95 50
All (10–30) 34 4.06 70.6 3.81 73.5
ModPep dataset
Length range Peptidesa CA-RMSD Percentb B-RMSD Percentb
7–10 279 3.16 88.9 2.91 91.4
11–15 134 4.96 58.2 4.75 61.9
16–25 88 5.88 51.1 5.44 55.7
All (7–25) 501 4.12 74.1 3.85 77.2
CA-RMSD C-alpha Root Mean Square Deviation, B-RMSD Backbone Root Mean
Square Deviation
aNumber of Peptides
bPercent of peptides with B-RMSD <5 Å
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etc. [2, 6, 39, 61, 62]. It becomes imperative to under-
stand the structural and functional aspects of the
peptides before undertaking systematic peptidomi-
metic approaches for designing therapeutic peptides
with desirable properties [63–65]. In this direction, an
attempt has been made to provide an online resource
(PEPstrMOD) to predict the structure of a peptide
from its sequence. Considering the importance of
different types of modifications (cyclization, L- to D-
conversion, non-natural residue, PTMs, capping of
terminal residues), which are incorporated to provide
therapeutic properties to the peptides, we integrated
special force field libraries in PEPstrMOD to handle
such peptides. We validated the PEPstrMOD applica-
tion using three datasets and demonstrated that
PEPstrMOD is able to approach near the native pep-
tide structure. To the best of authors’ knowledge,
PEPstrMOD is the only web server available currently
to the scientific community, which can handle diverse
modifications in peptides. We anticipate that PEPstr-
MOD will live up to the expectations of the re-
searchers working in the field of peptide therapeutics/
peptidomimetics.
Limitations
The length range of the peptide, which can be
modeled using PEPstrMOD, is 7 to 25 amino acids.
PEPstrMOD can handle only those non-natural/
modified amino acids, which are present in the force
field libraries (FFNCAA/FFPTM/SwissSideChain) in-
tegrated in the PEPstrMOD. In future, with the
availability of more force field libraries, it will be
possible to include other non-natural modifications
in PEPstrMOD.
Reviewer’s comments
Response to Prof. Michael Gromiha
In this work, the authors developed a method for pre-
dicting the structures of peptides containing natural and
non-natural/modified residues. This program included
six different types of peptides and desired modifications
at any sites. The predicted structures showed a good
agreement with experimental data. Further, a web server
has been developed for peptide design. The server is well
designed and sufficient details have been provided on
the web with various utilities. The work is interesting
and useful for designing peptides for desired therapeutic
Fig. 3 Graphical representation of the result page of PEPstrMOD with multiple tabs. a Visualization of the predicted structure
using Jmol Viewer. b Links to download PDB file of predicted structure, topology, coordinate, trajectory files and representative
structures from cluster analysis. c Energy graph of the simulation. d RMS graph of the simulation. e Visualization of the simulation in
animated form. f Visualization of the alignment of predicted structure and representative structures obtained after cluster analysis
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property. The following suggestions may be incorporated
for improvements.
Comment 1: It will be better to avoid using abbrevia-
tions in the abstract.
Authors’ response 1: In the revised manuscript, we
have removed the abbreviations from the abstract.
Comment 2: The source for obtaining experimental
data for validating the method may be included in the
abstract.
Authors’ response 2: As suggested by the reviewer, we
have provided more information on experimental data in
the abstract.
Comment 3: Page 6, psi value, −40 is split into two
lines.
Authors’ response 3: Correction has been made in the
revised version of the manuscript.
Comment 4: The time required to model the structure
based on different types and number of modifications
could be mentioned.
Authors’ response 4: We have provided the approximate
time required to build different types of models.
Comment 5: Table 3, it will be helpful to write the
explanations for the two methods in the footnote.
Authors’ response 5: Suggestions of the reviewer have
been incorporated in the revised version.
Comment 6: In Table 2, it will be informative to give
the meaning of the symbol B and the blank space.
Authors’ response 6: Table 2 has been modified as sug-
gested by the reviewer.
Comment 7: The advantages of the present method
over other related existing methods could be discussed.
Authors’ response 7: We have discussed the advantages
of the present method over existing methods in the revised
manuscript.
Comments from second revision: None
Response to Dr. Bojan Zagrovic
The manuscript by Singh et al. presents a server for
structure prediction of peptides with natural as well as
non-natural/modified residues. Given the importance of
natural and modified peptides in different areas of bio-
medicine and drug design, an effort in the direction of
their 3D structure prediction just from sequence is def-
initely timely and highly needed. The server presented
by the authors is well-designed and user friendly, but, as
more elaborated below, I have reservations against it be-
ing a reliable structure prediction tool.
Authors’ response: We are thankful to the reviewer for
appreciating our work and his constructive comments.
We have revised the manuscript and took following steps
to address all the issues raised by the reviewer.
(i) We have made a large dataset of 501 peptides with
different modifications and tested the performance of
PEPstrMOD on this dataset rather than testing on 8
peptides.
(ii)Out of 501 peptides, we extracted 16 peptides which
had regular secondary structure content ≥60 % and
tested the performance of PEPstrMOD on these 16
peptides.
(iii) In order to demonstrate advantages of PEPstrMOD
in building initial models, we also built structure of
peptides using extended conformation. We
compared the performance of models built using
PEPstrMOD and extended conformations.
(iv) The performance of PEPstrMOD depends on
predicted secondary structure so we also built
models where we used actual secondary structure
(generated using DSSP) instead of predicted
secondary structure, to check the maximum
performance, which can be achieved.
(v) We have performed ensemble-level comparison of
the predicted structures with NMR rigid core
regions. Rigid core regions are defined as the
residues, which exhibit <1.5 Å CA-RMS fluctuations
when all the models of the NMR structure are aligned
(PMID 19569182).
(vi) We extended the MD simulations from 100 ps to 1
ns and evaluated the effect of MD simulations on
accuracy of peptide structures.
(vii)We performed MD simulations in both vacuum
and hydrophilic environment and compared the
performance in both the environments.
Major comments
Comment 1: The key part of the manuscript is the val-
idation of the predictive capabilities of PEPstrMOD via a
comparison between predicted and experimentally deter-
mined structures of 8 peptides containing non-natural
residues and 4 pairs of peptides where both native and
modified structures are known. This analysis, however,
provides very little evidence that the algorithm is actu-
ally capable of quality predictions. For example, out of 8
peptides in Table 4, only 2 are predicted with a backbone
RMSD < 5 Å, too few to give any strong credence to the
claim that the algorithm can be used for structure pre-
diction with any sort of reliability.
Authors’ response 1: We agree with the reviewer that a
small dataset of 8 peptides is not sufficient for demon-
strating reliability of our method. Therefore, we replaced
our small dataset with a large dataset having 501 pep-
tides with different modifications (D-amino acids, non-
natural residues and post-translational modifications).
We evaluated the performance of PEPstrMOD on this
dataset and achieved an average C-alpha RMSD
(CA-RMSD) of 4.12 Å and Backbone-RMSD (B-RMSD) of
3.85 Å on this dataset. Out of 501 peptides, PEPstrMOD
was able to achieve <5 Å B-RMSD in 387 peptides
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(~77 %). In the rigid core regions, PEPstrMOD
achieved <5 Å B-RMSD in 399 peptides (~80 %)
(Additional file 2: Table S8). In the revised manuscript,
we used the above dataset of 501 peptides for demon-
strating the performance of our models.
Comment 2: The latter point is easily understood if
one consider the nature of the algorithm, which sim-
ply combines secondary structure/turn predictions
based on primary sequence using PSIPRED and Beta-
Turns softwares with very short molecular dynamics
(MD) runs (ca. 100 ps time-scale). On the one hand,
the difficult part of structure prediction is done by
PSIPRED and BetaTurns, but these algorithms are
themselves fraught with uncertainties of multiple
sorts. Putting these utilities together with an MD step
into one framework is the main contribution of
PEPstrMOD, but one should emphasize that on the
100 ps time-scale, as used by PEPstrMOD, MD is
nothing more than a tool for local relaxation of struc-
tures, which in many cases (see next comment) actu-
ally lowers the accuracy of the prediction.
Authors’ response 2: As pointed out by the reviewer,
the initial structure of a peptide is built using the re-
straints predicted by PSIPRED and BetaTurns. These
prediction methods have their own limitations. In order
to demonstrate advantages and limitations of these sec-
ondary structure prediction methods; we also built
models using actual secondary structure (DSSP gener-
ated) and extended conformations (no secondary struc-
ture information). We evaluated the performance of these
models on a subset of 16 peptides extracted from 501
peptides that contain secondary structure content of 60
% or more. We evaluated the performance of these
models on the initial structure, after energy minimization
and after simulations at 100 ps and 1 ns. As shown in
Additional file 2: Table S9, we achieved CA-RMSD
10.94 Å, 4.83 Å and 2.78 Å for ab initio (extended con-
formation), PEPstrMOD (predicted secondary structure)
and DSSP (actual secondary structure) based models re-
spectively. These results clearly demonstrate advantages
of PEPstrMOD over ab initio models, which is mainly
due to the predicted secondary structure. The better per-
formance of DSSP based methods demonstrates the limi-
tations of the methods (PSIPRED & BetaTurns) used for
predicting secondary structure.
Next, we computed the performance of models after
energy-minimization and achieved CA-RMSD 10.77 Å,
4.78 Å and 2.90 Å for ab initio, PEPstrMOD and DSSP
based models respectively. As shown in Additional file 2:
Table S9−S10, the performance of ab initio and PEPstr-
MOD improved slightly but it decreases slightly in case
of DSSP-based model. Finally, we computed the perform-
ance of our models after performing MD simulations at
100 ps. It was observed that performance of DSSP-based
models decreased after MD simulations. In case of
PEPstrMOD, the performance of models improved
after 100 ps simulation (CA-RMSD from 4.78–4.31 Å).
Interestingly, the performance of ab initio models im-
proved drastically from CA-RMSD 10.77–5.48 Å after
100 ps (Additional file 2: Table S11). We also tested
longer MD runs (up to 1 ns) and compared the perform-
ance of PEPstrMOD at both 100 ps and 1ns time steps.
We didn’t observe any significant improvement in the re-
sults by extending the MD run from 100 ps to 1 ns (Add-
itional file 2: Table S12). This may be due to the fact
that the initial structure predicted by PEPstrMOD is a
good starting structure and a short MD simulation is suf-
ficient to improve the structure.
Comment 3: While the average RMSD over the whole
test set presented in Table 4 does decrease after the mo-
lecular dynamics step, it turns out that the number of
solid predictions (RMSD < 5 Å) actually drops from 4 to
2 (Table 4). The drop in the average RMSD is only due
to an RMSD reduction for truly bad predictions (say, go-
ing from 14.56 Å to 8.20 Å for B–RMSD in the case of
the 2CEF structure), but the key point is that 8 Å predic-
tion is still as bad a prediction for a 19–residue peptide
as is the 14 Å prediction. In contrast to the authors’
claim on p. 12, this in my opinion cannot be used to say
anything about the quality of MD force fields in the task
at hand.
Authors’ response 3: We agree with the reviewer that
PEPstrMOD completely fails to predict the structure of
some peptides (RMSD >5 Å) but the performance was
evaluated on a small dataset (8 peptides). In the revised
manuscript we have validated PEPstrMOD method on a
large dataset of 501 peptides with different modifications
and achieved average CA-RMSD and B-RMSD of 4.12 Å
and 3.85 Å respectively. Out of 501 peptides, PEPstr-
MOD was able to achieve <5 Å B-RMSD in 387 peptides
(~77 %). In the rigid core regions, PEPstrMOD achieved
<5 Å B-RMSD in 399 peptides (~80 %) (Additional file 2:
Table S8). In the revised manuscript, we have shown the
performance of PEPstrMOD on a large dataset of 501
peptides.
Comment 4: An important point when it comes to
comparisons with experiment concerns the fact that
most of the peptides are quite flexible, with the experi-
mental NMR bundles in many cases exhibiting signifi-
cant structural diversity. Therefore, even the whole
concept of predicting the structure is undermined by the
fact that many of these peptides do not have a fixed
structure. Moreover, the authors in a way work against
themselves when trying to compare their predictions
against experiment, but only take into the account the
first NMR model. An ensemble-level prediction and
comparisons against experiment would be much more
appropriate in this case.
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Authors’ response 4: As suggested by the reviewer, we
have also performed ensemble-level comparisons of the
predicted structures with NMR rigid core regions. Rigid
core regions are defined as the residues, which exhibit
<1.5 Å CA-RMS fluctuations when all the models of the
NMR structure are aligned (PMID 19569182).
Comment 5: The comparison of the predicted struc-
tures of cyclized peptides with their experimentally de-
termined counterparts shows that PEPstrMOD performs
quite well and with a similar level of accuracy as the
competitor PEP-FOLD. However, one might argue that
the moment one connects the correct cysteine residues
in peptides via S-S bridges, the near-correct topology is
immediately attained, especially for very short peptides.
The authors should discuss this fact in more detail, and
also present a more thorough analysis of the cases where
their predictions failed (e.g. in about 1/3 of cases their
backbone RMSDs from the correct structure > 5 Å).
Authors’ response 5: We agree with the reviewer that
cyclic peptides have limited conformations as S-S bridge
may provide near-correct topology in the case of small
peptides. In order to demonstrate advantage of PEPstr-
MOD in predicting structure of cyclic peptides, we also
predicted the structure of cyclic peptides using ab initio
model where structure is built from extended conform-
ation using disulfide bond constraints and subjected to
MD simulations. As shown in Table 3, the performance
of PEPstrMOD model is better than ab initio models.
PEPstrMOD achieved an average CA-RMSD of 4.06 Å
where as ab initio model achieved an average CA-RMSD
of 5.04 Å after MD simulation of 100 ps. In the revised
manuscript, we have discussed this fact in detail and
have also provided a thorough analysis of the cases where
PEPstrMOD performance was poor.
Comment 6: The analysis that has lead to the data
given in Table 5 is not clearly explained. What do the
authors mean, when they say that “structure of original
peptide was used” (p. 12)? The authors should also pro-
vide a comparison between the predicted and the actual
structures of the modified peptides without using the
non-modified experimental structure of the peptide as
template.
Authors’ response 6: The dataset used in Table 5 is
very small (4 pairs of peptides) and we agree with the re-
viewer that validating any method on a very small data-
set doesn’t ensure the reliability of the method. Therefore,
in the revised manuscript we have now removed the re-
sults on this dataset i.e. Table 5. We have validated
PEPstrMOD on a new and large dataset of 501 peptides.
Comment 7: Overall, the webpage of the server is
nicely designed and implemented and one must appreci-
ate the amount of work that has gone into it. However,
for the reasons outlined above, I see its utility much less
as a peptide structure prediction engine in the strict
sense, but more as a useful tool for generating plausible
starting structures for MD simulations of modified pep-
tides. I doubt that, due to the inaccuracies involved, the
structures obtained by the server will have any strong
immediate practical value when it comes to drug design,
docking or structure modeling, except perhaps in the
case of cyclized molecules or as a starting point for fur-
ther studies.
Authors’ response 7: In the revised manuscript we have
validated the PEPstrMOD method on a large dataset of
501 peptides. Considering the challenging task of peptide
tertiary structure prediction directly from sequence,
PEPstrMOD achieved reasonable performance. We hope
that the revised manuscript will address the concerns
raised by the reviewer.
Minor comments
Comment 8: The discussion of different algorithms
for peptide structure prediction given in the introduc-
tion should include a more critical comparison of the
advantages and disadvantages of different algorithms
and not just a sheer listing of their names and basic
properties.
Authors’ response 8: We have modified the introduc-
tion and added the content as per the suggestion of the
reviewer.
Comment 9: The quality of the written English in the
manuscript as whole is good, but the text could still
benefit from a round of editing. In particular, there is a
number of places where definite or indefinite articles are
missing. Also, values of different variables and the asso-
ciated units should be separated. Finally, Table 2 should
be edited – currently some cells are filled with non-
standard characters whose meaning is difficult to
decipher.
Authors’ response 9: We have made appropriate
changes in the revised manuscript wherever required. We
are thankful to the reviewer for his suggestions that
helped us to improve the manuscript. In the revised
manuscript, we have corrected Table 2.
Comment 10: While the reference to the PTM param-
eters for GROMOS 45a3 and 54a7 is correct (ref. 37),
the reference to the Vienna PTM web server should be
included as: Margreitter et al. Nucleic Acids Research,
41, Web Server Issue, W422–W426.
Authors’ response 10: In the revised manuscript, we
have corrected the reference to the Vienna PTM web
server.
Comment 11: Description of the comparison for cy-
cled peptides is unclear - did or did not the authors in-
clude disulfide bond constraints with PEP-FOLD?
Authors’ response 11: Disulfide bond constraints were
included with PEP-FOLD and in the manuscript it is
represented by PEP-FOLDc where superscript ‘c’ stands
for ‘constraints’.
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Comments from second revision
The manuscript by Singh et al. presents a server for
structure prediction of peptides with natural as well as
non-natural/modified residues. Given the importance of
natural and modified peptides in different areas of bio-
medicine and drug design, an effort in the direction of
their 3D structure prediction just from sequence is def-
initely timely and highly needed. The server presented
by the authors is well designed and user friendly, and
has been validated and tested on a large dataset of 501
peptides.
While the performance of the algorithm as demon-
strated in the article is good, there are several points
which should be borne in mind when using it, and
which could in some (but, not all) applications lead to
difficulties. Namely, the algorithm combines secondary
structure/turn predictions based on primary sequence
using PSIPRED and BetaTurns software packages with
very short molecular dynamics (MD) runs (100 ps time-
scale). On the one hand, the difficult part of structure
prediction is done by PSIPRED and BetaTurns, but these
algorithms are themselves fraught with uncertainties of
multiple sorts. Putting these utilities together with an
MD step into one framework is the main contribution of
PEPstrMOD, but one should emphasize that on the
100 ps time-scale, as used by PEPstrMOD, MD is noth-
ing more than a tool for local relaxation of structures,
which in some cases could actually lower the accuracy
of the prediction. Finally, an important point when it
comes to comparisons with experiment concerns the
fact that many peptides are quite flexible, with the ex-
perimental NMR bundles in many cases exhibiting sig-
nificant structural diversity. Therefore, even the whole
concept of predicting the structure may be undermined
by the fact that many of these peptides do not have a
fixed structure. While the authors clearly show that the
structures of the more stable and rigid parts of peptides
can be accurately predicted, practical users should keep
in mind that the more flexible parts might simply be
floppy and could only be accurately described by using
extensive MD simulations or similar methods. In this
sense, I see the utility of the algorithm both as a peptide
structure prediction engine, but also as a useful tool for
generating plausible starting structures for MD simula-
tions of modified peptides.
Authors’ response: We are thankful to the reviewer for
appreciating our work. The comments and suggestions of
the reviewers helped us to improve our work.
Response to Dr. Zoltan Gaspari
The authors describe a web service for structure prediction
of peptides containing modified/unnatural amino acids.
They developed a pipeline using AMBER or GROMACS,
depending on the available force field parameters for
the given amino acids in the peptide. I feel that the
concept is useful but I am not fully satisfied with the
presentation of the results. In particular, I would like
to ask the authors to address the following points:
Authors’ response: We are thankful to the reviewer for
appreciating our work and his constructive comments.
We have revised the manuscript and took following steps
to address all the issues raised by the reviewer.
(i) We have made a large dataset of 501 peptides with
different modifications and tested the performance of
PEPstrMOD on this dataset rather than testing on 8
peptides.
(ii) Out of 501 peptides, we extracted 16 peptides which
had regular secondary structure content ≥60 % and
tested the performance of PEPstrMOD on these 16
peptides.
(iii) In order to demonstrate advantages of PEPstrMOD
in building initial models, we also built structure of
peptides using extended conformation. We compared
the performance of models built using PEPstrMOD
and extended conformations.
(iv)The performance of PEPstrMOD depends on
predicted secondary structure so we also built
models where we used actual secondary structure
(generated using DSSP) instead of predicted
secondary structure, to check the maximum
performance, which can be achieved.
(v) We have performed ensemble-level comparison of
the predicted structures with NMR rigid core regions.
Rigid core regions are defined as the residues, which
exhibit <1.5 Å CA-RMS fluctuations when all the
models of the NMR structure are aligned (PMID
19569182).
(vi)We extended the MD simulations from 100 ps to 1
ns and evaluated the effect of MD simulations on
accuracy of peptide structures.
(vii)We performed MD simulations in both vacuum
and hydrophilic environment and compared the
performance in both the environments.
Comment 1: I would like to see more details about the
conformation assigned to the ‘X’ amino acids. For
example, for residues in the D configuration, are the
L-counterparts taken into account or are they also
treated as ‘X’? It would be worth to analyze how this
influences the prediction of secondary structures and
to what extent the differences between predicted and
actual structures - where it can be assessed - come
from erroneous assignment of the starting conform-
ation of the ‘X’ residue.
Authors’ response 1: Only non-natural amino acids
are converted to ‘X’ amino acid prior to secondary struc-
ture prediction step using PSIPRED. Therefore, residues
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in D configuration are not converted to ‘X’. Rather hand-
ling of D-amino acids is done using AMBER command
‘flip’ which flips the stereochemistry of the selected resi-
due. Similarly, residues with post-translational modifica-
tions (like 5hydroxy-lysine) are not converted into ‘X’ and
the original residue is retained as such, prior to PSIPRED
step. This is also represented in Fig. 1 where residue ly-
sine is retained as such, prior to PSIPRED step, while
non-natural residue diethylalanine is converted to ‘X’.
Comment 2: In connection, it would be useful to in-
clude/refer to a critical evaluation of the incorporated
secondary structure prediction methods for some un-
modified peptides. Also, I am not fully convinced that
the backbone torsion angles 180/180 can be referred to
as ‘ideal’ for ‘coil’ residues as ‘coil’ refers to everything
that is not alpha-helix of beta-sheet in this context.
Authors’ response 2: The effect of incorporation of pre-
dicted secondary structure restraints in the prediction
method for unmodified peptides has already been shown
in the PEPstr algorithm [PMID 17897087]. Briefly, after
applying the secondary structure restraints to the ex-
tended conformation, followed by energy minimization,
the RMSD decreased from 7.1 Å to 4.4 Å.
As pointed out by the reviewer, to demonstrate the ad-
vantages and the limitations of these secondary structure
prediction methods; we also built models using actual
secondary structure (DSSP generated) and extended con-
formations (no secondary structure information). We
evaluated the performance of these models on a subset of
16 peptides extracted from 501 peptides that contain sec-
ondary structure content of 60 % or more. We evaluated
the performance of these models on initial structure, after
energy minimization and after simulations at 100 ps and
1 ns. As shown in Additional file 2: Table S9, we achieved
CA-RMSD 10.94 Å, 4.83 Å and 2.78 Å for ab initio (ex-
tended conformation), PEPstrMOD (predicted secondary
structure) and DSSP (actual secondary structure) based
models respectively. These results clearly demonstrate the
advantages of PEPstrMOD over ab initio models, which
is mainly due to the predicted secondary structure. The
better performance of DSSP based methods demonstrates
the limitations of methods (PSIPRED & BetaTurns) used
for predicting secondary structure.
Next, we computed the performance of models after
energy-minimization and achieved CA-RMSD 10.77 Å,
4.78 Å and 2.90 Å for ab initio, PEPstrMOD and DSSP
based models respectively. As shown in Additional file 2:
Table S9−S10, the performance of ab initio and PEPstr-
MOD improved slightly but it decreases slightly in the
case of DSSP-based model. Finally, we computed the per-
formance of our models after performing MD simulations
at 100 ps. It was observed that the performance of DSSP-
based models decreased after MD simulations. In case of
PEPstrMOD, the performance of models improved
after 100 ps simulation (CA-RMSD from 4.78–4.31 Å).
Interestingly, the performance of ab initio models im-
proved drastically from CA-RMSD 10.77–5.48 Å after
100 ps (Additional file 2: Table S11). We also tested
longer MD runs (up to 1 ns) and compared the perform-
ance of PEPstrMOD at both 100 ps and 1 ns time steps.
We didn’t observe any significant improvement in the re-
sults by extending the MD run from 100 ps to 1 ns
(Additional file 2: Table S12). This may be due to the
fact that the initial structure predicted by PEPstrMOD is
a good starting structure and a short MD simulation is
sufficient to improve the structure.
We agree with the reviewer that the backbone torsion
angles 180/180 cannot be referred to as ideal for coil resi-
dues, instead they are used to make an extended (linear)
conformation. In the revised manuscript, we have modi-
fied the statement and have added the details of the
above experiment along with its discussion.
Comment 3: In the evaluation of correspondence of
predicted vs, experimental structures I would like to see
the final predicted torsion angles as they might be more
informative than RMSD values. in particular, even if an
RMSD is relatively high, some important aspects of the
structure, the presence of an important local structural
motif might be predicted accurately. For structures
where NMR restraints are available it could be also use-
ful to analyze the correspondence of the predicted struc-
tures to these.
Authors’ response 3: As suggested by the reviewer, we
have now performed ensemble-level comparison of the
predicted structures with NMR rigid core regions. Rigid
core regions are defined as the residues, which exhibit
<1.5 Å CA-RMS fluctuations when all the models of the
NMR structure are aligned (PMID 19569182). Therefore,
comparison of the structures only in the rigid core re-
gions provides more detailed analysis of the prediction
methods.
Comment 4: The limitations of the method should be
discussed, i.e. what is the maximum length of a peptide
that can be predicted within a reasonable time and how
many nonstandard residues are allowed. E.g. are two
consecutive modified residues allowed/expected to be
modeled accurately?
Authors’ response 4: In the revised manuscript we have
discussed the limitations of the methods with respect to
the maximum length of the peptide that can be pre-
dicted. An approximate time required to model the struc-
ture with different modifications is also discussed.
Two consecutive modified residues can be modeled
using PEPstrMOD. Moreover, the newly created dataset
of 501 peptides on which PEPstrMOD is validated, con-
tains such entries with two and even three consecutive
modified residues. However, such entries with consecutive
residues are less in number (26 out of 501). PEPstrMOD
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also provides the provision to model multiple non-
consecutive modified residues, which are also present in
the new dataset of 501 peptides.
Comment 5: Have the authors tested longer MD runs/
simulated annealing protocols? Please comment on this
whether any of these could be expected to improve the
results.
Authors’ response 5: As per the suggestion of the re-
viewer, we tested longer MD runs (up to 1 ns) and com-
pared the performance of PEPstrMOD. We observed no
significant improvement in the results by extending MD
simulation up to 1 ns. Briefly, on ‘Cyclicpep’ dataset (34
cyclic peptides), PEPstrMOD achieved an average CA-
RMSD of 4.06 Å and 4.10 Å at 100 ps and 1 ns time
steps respectively (Additional file 2: Table S5). However,
repeating the same experiment while performing MD
simulation in hydrophilic environment, a slight improve-
ment was observed in the performance of PEPstrMOD
from 3.97 Å to 3.82 Å at 100 ps and 1 ns time steps
respectively (Additional file 2: Table S6).
On 16 peptides (with regular secondary structure
content ≥60 %), PEPstrMOD achieved an average CA-
RMSD of 4.31 Å and 4.48 Å at 100 ps and 1 ns time
steps respectively. Performing same experiment with
MD simulation in hydrophilic environment, PEPstr-
MOD achieved average CA-RMSD of 4.35 Å and
4.36 Å respectively (Additional file 2: Table S11−S12,
S13-S14).
Comments from second revision
The authors have put a lot of work into improving the
manuscript compared to the initial version and I appre-
ciate their efforts. The authors have extended their com-
parison methodology even though I did not get a direct
answer for my point about torsion angles and NMR re-
straints. I think that the manuscript is now suitable for
publication.
Authors’ response: We are thankful to the reviewer for
appreciating our work. The comments and suggestions of
the reviewers helped us to improve our work.
Additional files
Additional file 1: List of modified residues integrated in PEPstrMOD;
AMBER and GROMACS parameters for performing Molecular
Dynamics. Table S1. Types of non-natural amino acids present in FFNCAA
and SwissSideChain Force field libraries. Table S2. Types of PTMs available
in FFPTM force field library. Table S3. AMBER parameters for performing
energy minimization and molecular dynamics using AMBER11. Table S4.
GROMACS parameters for performing energy minimization and molecular
dynamics using GROMACS-4.6.5. (PDF 50 kb)
Additional file 2: Performance of PEPstrMOD on CyclicPep, ModPep
and ModPep16 datasets. Table S5. Performance comparison of
PEPstrMODpc with PEP-FOLDc and ab initio model on CyclicPep dataset in
vacuum environment. Table S6. Performance comparison of PEPstrMODpc
and ab initio model on CyclicPep dataset in hydrophilic environment.
Table S7. Performance of PEPstrMOD, PEP-FOLD and PepLook on 28 cyclic
peptides. Table S8. Performance of PEPstrMOD on ModPep dataset.
Table S9. Comparison of the performance of initial structures of PEPstrMOD,
ab initio and DSSP models on ModPep16 dataset. Table S10. Comparison
of the performance of minimized structures of PEPstrMOD, ab initio and
DSSP models on ModPep16 dataset in vacuum environment. Table S11.
Comparison of the performance of structures of PEPstrMOD, ab initio
and DSSP models on ModPep16 dataset in vacuum environment
after 100 ps MD. Table S12. Comparison of the performance of
structures of PEPstrMOD, ab initio and DSSP models on ModPep16
dataset in vacuum environment after 1 ns MD. Table S13. Comparison of
the performance of minimized structures of PEPstrMOD, ab initio and DSSP
models on ModPep16 dataset in hydrophilic environment. Table S14.
Comparison of the performance of structures of PEPstrMOD, ab initio
and DSSP models on ModPep16 dataset in hydrophilic environment
after 100 ps MD. Table S15. Comparison of the performance of
structures of PEPstrMOD, ab initio and DSSP models on ModPep16
dataset in hydrophilic environment after 1 ns MD. (XLSX 176 kb)
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